Artermether Lumefantrine Antimalaral Western Medicine Artem Artemether 40/240 Artermether

Model NO.
tablets
Pharmaceutical Technology
Natural Product Extraction
Active
Artermether Lumefantrine
Product Name
Artermether Lumefantrine Tablets
Transport Package
Box
Specification
80mg
Trademark
sunbiolab
Origin
China
Production Capacity
500000box/Month
Reference Price
$ 0.81 - 0.90

Product Description

Artermether Lumefantrine Antimalaral Western Medicine Artem Artemether 40/240 Artermether
Artermether Lumefantrine Antimalaral Western Medicine Artem Artemether 40/240 Artermether
Name:DMSCARE-Artermether/lumefantrine Tablet
Package: 6 tablets/blister *1 box.  400 boxes/carton
Contains for one unite:
Artermether 80mg/lumefantrine 480mg
DMS Chemical Pharmaceutical Inc. Ltd., is a professional pharmaceutical company focusing on international market of finished medicines.
To supply sustainable, high quality products, competitive price and satisfactory service is our mission. We won high recognition in the international market by professional product knowledge, efficient supply chain management and excellent service, establishing extensive and mature distribution channels in international market. Professionalism, honesty and integrity are our cultures. We will try our best to offer good quality products with competitive prices and fast delivery for our customers. We are looking forward to setting up long-term cooperation relationship with you.

DMS Company Mission
1- To achieve highest end-consumer satisfaction by providing quality products at affordable prices.
2- To provide new solutions for the age-old and new disorders and diseases by comprehensive Research and Development work.
4- To remain up to date with the latest knowledge and technology in the pharmaceutical industry.
5- And above all, our highest goal is to strengthen the health of the country and the entire world by our range of products and services.
Artermether Lumefantrine Antimalaral Western Medicine Artem Artemether 40/240 Artermether






 

 

PNEUTEC.IT, 2023